13/07/2022 – HMP convinces investors: closed the first round with results above expectations

A first, decisive financial milestone for HMP: the initial investment round has been successfully completed, raising approximately €135,000. This sum will be used to cover key activities for the project's growth, including market research, an estimate of the value of the intellectual property, an in-depth technology assessment, and the filing of the "Confirmation" of the European pre-patent application.

The capital was raised in just 30 days, thanks to the entry of new capital partners, who strongly believed in the vision proposed by HMP.

At the same time, there's an even stronger signal of confidence in the project: key professionals, including a psychologist, an engineer, and a software developer, have chosen to voluntarily contribute to the operational work, without financial compensation. Their highly qualified contributions represent a tangible added value to the investments raised.

The new collaborators will work closely with the healthcare team, led by CEO Dr. Giovanni Maresca, to develop the first proof-of-concept prototype, which will serve as the company's true technical and operational testbed.